Calls For Abstracts
Quick Links
The 72nd ACR Annual Scientific meeting in San Francisco will offer the latest basic science and clinical information through pre-conference sessions, multiple types of informative scientific meeting symposia and themed abstract sessions featuring the research of seasoned rheumatologists and health professional as well as up-and-coming trainees and medical students.
You are invited to submit your abstract and take advantage of the opportunity to share your work with colleagues and receive potential recognition for these efforts.
The abstract submission guidelines for the ACR special abstract categories e.g., late-breaking and fellow-in-training are detailed in the Call for Abstracts (available online in PDF format) and in the Submission Guidelines throughout the online submission program; they are summarized here.
Abstract Processing Fees
Late-Breaking Abstract
A $130 processing fee (in U.S. funds) must accompany each abstract. The late-breaking abstract category allows for the submission of truly late-breaking scientific research for which no preliminary data are available at the time of the May 1, 2008, abstract submission deadline.
This category is not a mechanism to allow for updated data to be submitted later when preliminary data are available by the abstract submission deadline. Abstracts may be selected for oral or poster presentations. It is likely that no more than 20 percent of late-breaking submissions will be accepted for presentation.
Fellow-in-Training Abstract
A $60 processing fee (in U.S. funds) must accompany each abstract. The ACR offers a special fellow-in-training abstract category with a deadline of August 11, 2008.
There is no acceptance rate advantage to submitting to the fellow-in-training abstract category; nor will abstracts submitted to the May deadline be reconsidered for presentation.
Abstract Format
The abstract limit is 2,750 characters, including the title and authors, not including spacing or disclosures. In addition, if you import tables and graphics, your character count will be decreased by 250 characters from the total limit allowed. Your abstract will be considered “incomplete” if you exceed the limit.
Omit all names and geographical references in the body of the abstract. Authors should organize abstract content in four sections: background/purpose, methods, results and conclusions, identifiable by bold headers.
Research Method, Treatment Trial Phases and Types of Clinical Trials
Presenting Author Responsibilities
The presenting author will be the sole point of contact for information regarding the submission and is responsible for the following:
- Ensuring each co-author is aware of the contents of the abstract and supports its data.
- Ensuring each co-author is aware of the disclosure requirements.
- Presenting the abstract or arranging a co-author to present the abstract if it is selected for presentation during an oral and/or poster abstract session.
- Forwarding abstract acceptance/rejection notification, and ACCME and ACR policies to each co-author.
Acceptance for Presentation
The Presenting Author will be notified via e-mail in August. The Presenting Author is the only author who will receive notification and is the point of contact for all co-authors listed on the abstract. Only coauthors listed on the abstract may present the abstract in the event that the Presenting Author is not available. (This includes poster presentations.) The late-breaking and fellow-in-training presenting authors will be notified in September.
Accepted abstracts will be published in the supplement of the September issue of Arthritis & Rheumatism, the official journal of the American College of Rheumatology. Accepted late-breaking and fellow-in-training abstracts will be published in the December issue of Arthritis & Rheumatism. All accepted abstracts will be available on the ACR Web site in September.
Eligibility
Late – Breaking Abstract Category
- The abstract must deal only with clinical research.
- Case reports are not considered appropriate and will not be reviewed.
- The presenting author will be required to identify a primary research category e.g., Clinical,
Observational, Interventional, etc. This must be indicted on the online submission form.
- If the abstract reports results of a clinical trial not yet approved by a regulatory agency, the
presenting author will be required to identify the trial phase. This must be indicated on the online submission form.
- Abstracts should present data that is ground-breaking, innovative and has a high impact factor.
- Abstracts should present data of high significance and timely findings that were not available at the time of the May 1, 2008, abstract submission deadline.
Fellow-in-Training Abstract Category
- For the purpose of qualifying, you must be a fellow-in-training who is enrolled or who has just completed an ACGME accredited rheumatology training program at the time of the August 11, 2008, submission deadline. A letter from your program director, chief of services or faculty advisor verifying your status as a rheumatology fellow-in-training must be included with your abstract submission.
- Case reports are not considered appropriate and will not be reviewed.
- Abstracts submitted to the May 1, 2008 deadline are not eligible for submission to this category and will not be considered for presentation.
Presentation Format
- Abstracts are presented by poster, providing an intimate forum for informal discussion or by podium, which is a 15-minute oral presentation that includes a question/answer period.
- The presenting author is required to speak English when presenting.
- Accepted late-breaking abstracts will be presented as posters on Monday, October 27, 2008, during Poster Session B. The posters will be displayed from 9:00 am – 6:00 pm. Authors will be expected to man their posters during the scheduled poster presentation time from 9:00 – 11:00 am. The late-breaking oral abstracts will be presented on October 28 from 2:30-4:00 pm.
- Accepted fellow-in-training abstracts will be presented as posters on Monday, October 27, 2008, during Poster Session B. The posters will be displayed from 9:00 am – 6:00 pm. Authors will be expected to man their posters during the scheduled poster presentation time from 9:00 – 11:00 am.
New 2008 - Guided Poster Tours
Guided poster tours, lead by experts in the field, will guide small groups of attendees through the poster presentations highlighting novel or recent developments. Selected posters from varied abstract categories will be included in the tour. Categories will be announced in May.
Online Revisions
Revisions prior to the August 11 deadline will be accepted. No revisions to the abstract or list of authors will be accepted after the deadline – no exceptions.
Abstract Disclosure Statement
All authors must disclose any relevant financial relationship(s) at the time of abstract submission.
Abstract Withdrawals
If an abstract must be withdrawn, the presenting author must submit a written request to . Include the Presenting Author’s first and last name and title of the abstract.
Back to General Information
